Neurology Account Director - New York Metro
About the role
The Neurology Account Director (NAD) is a field-based institutional key account role responsible for driving the launch and ongoing commercial performance of Regeneron's C5 inhibitor for generalized myasthenia gravis (gMG) within approximately 10 - 12 assigned academic medical centers (AMCs) infusion centers, and neuromuscular specialty centers.
Responsibilities
Own and manage a portfolio of approximately 10 -12 AMCs and neuromuscular specialty centers within an assigned U.S. region, serving as the institutional commercial lead.
Develop and execute comprehensive account plans for each institution, including formulary strategy, stakeholder mapping, competitive positioning, and patient access pathways.
Navigate complex institutional buying environments including P&T committees, pharmacy contracting, hospital administration, and infusion center operations.
Build and maintain deep, trust-based relationships with neurology department heads, treating neurologists, clinical pharmacists, infusion nurses, and medical directors.
Formulary & Market Access Pull-Through: Lead formulary and pathway submissions and P&T committee presentations at targeted institutions, positioning the C5 inhibitor for preferred or unrestricted formulary status. Partner with Market Access National and Payer Account Directors to align institutional contracting with broader payer strategy and resolve prior authorization barriers. Coordinate with specialty pharmacy partners and Patient Services hub to ensure seamless reimbursement workflows for buy-and-bill infusion products. Track formulary status, pull-through metrics, and access barriers across all assigned accounts; escalate systemic issues with data-driven recommendations.
Stakeholder & KOL Engagement: Identify, develop, and maintain relationships with key opinion leaders (KOLs) in neuromuscular medicine within assigned territory, in coordination with Medical Affairs. Represent Regeneron at national and regional neurology congresses (AAN, MGFA), medical education events, and institutional grand rounds as appropriate.
Analytics, Planning & Reporting: Maintain detailed CRM records and account intelligence; leverage IQVIA/Symphony Health data for prescriber-level targeting and performance measurement. Track and report on KPIs including accounts engaged, formulary inclusions achieved, patient switches, revenue per account, and competitive share of voice. Prepare and present quarterly business reviews to the Executive Director, highlighting account progress, barriers, competitive dynamics, and resource needs. Contribute to territory realignment recommendations and Year 2 expansion planning based on field-level market intelligence.
Requirements
Bachelor's degree required; PharmD, RN, or advanced degree in life sciences strongly preferred.
Minimum 10-12+ years institutional sales, market access, or account management experience in pharmaceutical/biotech.
Demonstrated experience with hospital/AMC formulary processes, P&T committee engagement, and institutional buy-and-bill contracting.
Track record of success in rare disease, neurology, or specialty biologic sales/account management, ideally including launch experience.
Strong clinical acumen with the ability to engage physicians, pharmacists, and medical directors in scientifically rigorous conversations.
Experience executing competitive switch or conversion strategies in institutional settings.
Proficiency with CRM systems and commercial analytics platforms (IQVIA, Symphony Health, specialty pharmacy data).
Ability to manage complex, multi-stakeholder account relationships independently with minimal supervision.
Willingness to travel 60-70% within assigned territory, including overnight travel.
Qualifications
Candidates must reside within the assigned territory.
Preferred Experience: in complement biology, neuromuscular disease, or C5/FcRn inhibitor markets; existing relationships with neurology KOLs or MGFA-recognized center-of-excellence leadership; prior experience with infusion biologic launches in hospital/outpatient infusion settings; knowledge of specialty pharmacy hub operations, patient assistance programs, and prior authorization workflows; understanding of medical benefit (Part B) reimbursement, ASP pricing dynamics, and buy-and-bill economics.
Skills
Clinical Credibility: Translates C5 mechanism of action, dosing differentiation, and clinical evidence into compelling value propositions that resonate with treating physicians and institutional decision-makers.
Institutional Account Navigation: Expertly engages across all levels of AMC hierarchies, from neurology fellows to C-suite administrators, pharmacy directors to infusion center leadership.
Strategic Account Planning: Builds data-driven, multi-quarter account strategies that address formulary access, competitive positioning, and patient journey barriers.
Patient Journey Management: Coordinates cross-functionally with Patient Services, specialty pharmacy, and market access to remove barriers and ensure seamless treatment initiation and continuation.
Relationship Building: Develops deep, trust-based institutional partnerships that create long-term competitive advantages in rare neuromuscular disease.
Results Orientation: Drives measurable outcomes through disciplined account planning, KPI tracking, and relentless follow-through on formulary wins.
Benefits
Not specified.
Pay
$183,100.00 - $305,200.00 annually
Schedule
Remote role